Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NEU2 | Q9Y3R4 | 3/20 | 0.46 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.46 |
| ▸ | NEU3 | Q9UQ49 | 2/20 | 0.46 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.46 |
| ▸ | SELL | P14151 | 1/20 | 0.42 |
| ▸ | SELP | P16109 | 1/20 | 0.42 |
| ▸ | MAG | P20916 | 2/20 | 0.41 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4284548 | 1.00 | NANP (0.53) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL4943493 | 0.88 | L3MBTL1 (0.42) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL468825 | 0.86 | NANP (0.54) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL13926096 | 0.86 | NANP (0.54) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL15491955 | 0.86 | NANP (0.54) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL8675353 | 0.86 | NANP (0.49) | NANPNEU1SELLSELPMAG | |
| Sialic Acid SCHEMBL30437228 | 0.85 | NANP (0.71) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL19664236 | 0.85 | NANP (0.71) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL17963743 | 0.85 | NANP (0.71) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL12391931 | 0.85 | NANP (0.53) | NANPL3MBTL1NEU2NEU4NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16407 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12038447-B2 | Lipid bilayer membrane mimic | Sellergren, Börje (SE) | 2024-07-16 | — | — | US | claimed |
| WO-2024148337-A1 | METHODS AND COMPOSITIONS FOR GENE TRANSDUCTION AND TO CONTROL THE ACTIVITY OF SYNTHETIC AND IMMUNE RECEPTORS | ANGELES THERAPEUTICS, INC. (US) | 2024-07-11 | — | — | WO | claimed |
| EP-4396583-A1 | USE OF LECTINS TO DETERMINE MAMMAGLOBIN-A GLYCOFORMS IN BREAST CANCER | Glycanostics s.r.o. (SK) | 2024-07-10 | — | — | EP | claimed |
| CN-118317791-A | Combination therapy using immune cell adapter proteins and immunomodulators | 哈普恩治疗公司 | 2024-07-09 | — | — | CN | claimed |
| US-20240216510-A1 | CHIMERIC ANTIGEN RECEPTORS TO SIALYL-TN GLYCAN ANTIGEN | UNIV RAMOT (IL) | 2024-07-04 | — | — | US | claimed |
| EP-4392780-A1 | GLYCOPROTEIN BIOMARKERS FOR DIAGNOSING CANCER | Glycanostics s.r.o. (SK) | 2024-07-03 | — | — | EP | claimed |
| EP-3380620-B1 | OPTIMIZED LENTIVIRAL TRANSFER VECTORS AND USES THEREOF | NOVARTIS AG (CH) | 2024-07-03 | — | — | EP | claimed |
| CN-118251414-A | Prolonged release immune cell adaptor proteins and methods of treatment | 哈普恩治疗公司 | 2024-06-25 | — | — | CN | claimed |
| US-12018080-B2 | Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway | THE BROAD INSTITUTE, INC. (US) | 2024-06-25 | — | — | US | claimed |
| CN-118222461-A | Saliva combined lactobacillus Lumine-102 with whitening and antioxidation effects and application thereof | 北京量化健康科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| WO-1990012090-A1 | PROCESS FOR THE SEPARATION AND PURIFICATION OF SIALYL TRANSFERASES | CHEMBIOMED LTD. (CA) | 1990-10-18 | — | — | WO | claimed |
| EP-0381310-A1 | Monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides and method for production thereof | The Biomembrane Institute (US) | 1990-08-08 | — | — | EP | claimed |
| EP-0351045-A2 | Monoclonal antibody NUH2 capable of inactivating motility of sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen | The Biomembrane Institute (US) | 1990-01-17 | — | — | EP | claimed |
| EP-0328420-A2 | Gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology | The Biomembrane Institute (US) | 1989-08-16 | — | — | EP | claimed |
| EP-0319253-A2 | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation | ALBERTA RESEARCH COUNCIL (CA) | 1989-06-07 | — | — | EP | claimed |
| EP-0272603-A2 | Method for measuring glycosyltransferase | KONICA CORPORATION (JP) | 1988-06-29 | — | — | EP | claimed |
| EP-0251304-A2 | Glycosyl derivatives and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1988-01-07 | — | — | EP | claimed |
| US-4695541-A | Enzymatic detection of bacterial capsular polysaccharide antigens | MOLECULAR DIAGNOSTICS, INC. (US) | 1987-09-22 | — | — | US | claimed |
| US-4670539-A | CANCER DIAGNOSIS ANF THERAPY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS (US) | 1987-06-02 | — | — | US | claimed |
| US-4344936-A | Platelet composition having improved storage stability and method therefor | SOSLAU GERALD | 1982-08-17 | — | — | US | claimed |